Boston Scientific Corporation Message Board

favela808 favela808 • Jun 5, 2012 12:56 PM Flag

0 users liked this posts users disliked this posts 5

Reply

CTTC
Someone tell me if they have ever seen these kind of results to a chronic pain study? Out of JOHNS HOPKINS. A 95% reduction in pain with NO side effects. (are you kidding?)

http://abstract.asco.org/AbstView_114_96734.html

BSX should buy this company. (CTTC) Only a 15 million market cap.
Sort: Newest | Oldest | Most Replied Expand all replies
- ma45342312 ma45342312 • Jun 5, 2012 3:20 PM Flag
  
  0 users liked this posts users disliked this posts 3
  
  Reply
  CTTC
  
  I would completely believe this study. John Hopkins is a very very reputable research facility. Also the use of electrical stimulation to a given nerve to block pain is well known to be an effective treatment to reduce or alleviate pain.
  
  I do not see BSX buying this company as they have already a neuromodulation division. This product is different then the BSX offering but is it enough different for them to consider buying it. I do not know.
  
  http://www.bostonscientific.com/Device.bsci?page=HCP_Overview&navRelId=1000.1003&method=DevDetailHCP&id=10068931&pageDisclaimer=Disclaimer.ProductPage

Back To Board

Previous topic Next topic

BSX

9.100.06(+0.66%)May 17 4:00 PMEDT